𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Microarray analyses in bladder cancer cells: Inhibition of hTERT expression down-regulates EGFR

✍ Scribed by Kai Kraemer; Uta Schmidt; Susanne Fuessel; Alexander Herr; Manfred P. Wirth; Axel Meye

Publisher
John Wiley and Sons
Year
2006
Tongue
French
Weight
270 KB
Volume
119
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

The human telomerase reverse transcriptase (hTERT) contributes to the immortal phenotype of the majority of cancers. Targeting hTERT by transfection with antisense oligonucleotides (AS‐ODNs) induced immediate growth inhibition in human bladder cancer (BCa) cells. The molecular basis of the antiproliferative capacity of hTERT AS‐ODNs was investigated by oligonucleotide microarray analyses and was compared to effects caused by siRNA‐mediated knock‐down of hTERT in EJ28 BCa cells. Two different AS‐ODNs—both down‐regulated the expression of hTERT—changed the expression of different genes mainly involved in stress response (including EGR1, ATF3 and GDF15), but without an association to telomerase function. This indicates that the immediate growth inhibition was caused, at least in part, by off‐target effects. In comparison to that the blockade of the expression of hTERT using 2 different siRNAs was accompanied by the down‐regulation of the oncogenes FOS‐like antigen 1 (FOSL1) and epidermal growth factor receptor (EGFR), known to be overexpressed in BCa. We show here for the first time that repression of the hTERT transcript number decreased the expression of EGFR both at the mRNA and protein levels, suggesting a potential new function of hTERT in the regulation of EGFR‐stimulated proliferation. Furthermore, the suppression of hTERT by siRNAs caused an enhancement of the antiproliferative capacity of the chemotherapeutics mitomycin C and cisplatin. The results presented herein may support the hypothesis that hTERT promotes the growth of tumor cells by mechanisms independent from telomere lengthening. The detailed clarification of these processes will shed light on the question, whether telomerase inhibitors might constitute suitable anticancer tools. © 2006 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Periostin is down-regulated in high grad
Periostin is down-regulated in high grade human bladder cancers and suppresses in vitro cell invasiveness and in vivo metastasis of cancer cells
✍ Chul Jang Kim; Naohisa Yoshioka; Yukihiro Tambe; Ryoji Kushima; Yusaku Okada; Hi 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 477 KB 👁 1 views

We have previously reported that expression of periostin mRNA is markedly reduced in a variety of human cancer cell lines, suggesting that downregulation of periostin mRNA expression is correlated with the development of human cancers. In our study, to clarify the role of the periostin in human blad

Inhibition of proliferation and inductio
Inhibition of proliferation and induction of apoptosis in breast cancer cells by the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor ZD1839 (‘Iressa’) is independent of EGFR expression level
✍ Manuela Campiglio; Alberta Locatelli; Clelia Olgiati; Nicola Normanno; Giulia So 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 297 KB 👁 2 views

High expression of the epidermal growth factor receptor (EGFR) in breast carcinoma confers a growth advantage to the tumor cells. The EGFR tyrosine kinase inhibitor (EGFR-TKI) ZD1839 ('Iressa') has clinical activity in a wide range of tumor types, although the mechanism(s) by which it exerts its ant

Down-regulation of the transcriptional m
Down-regulation of the transcriptional mediator subunit Med1 contributes to the loss of expression of metastasis-associated dapk1 in human cancers and cancer cells
✍ Padmaja Gade; Ashish K. Singh; Sanjit K. Roy; Sekhar P. Reddy; Dhananjaya V. Kal 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 396 KB

## Abstract DAPK1, a ca^+2^/calmodulin regulated serine/threonine kinase, is a major tumor suppressor, whose expression is lost in multiple tumor types. However, the mechanisms contributing to it are unclear. We have recently shown that CCAAT/Enhancer binding protein‐β (C/EBP‐β) is required for the

Elevated expression of the estrogen rece
Elevated expression of the estrogen receptor prevents the down-regulation of p21Waf1/Cip1 in hormone dependent breast cancer cells
✍ Helen Zhao; Jenny Yu; Cheryl P. Peltier; Dr. James R. Davie 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 240 KB

## Abstract Expression of an estrogen receptor α (ER) transgene in hormone independent breast cancer and normal breast epithelial cells arrests cell cycling when estradiol is added. Although endogenously expressed ER does not typically affect estradiol‐induced cell cycling of hormone dependent brea